A Phase 1 Open-label Study to Evaluate Safety in Healthy Participants and Participants With Autoimmune Diseases
NCT07284797
·
clinicaltrials.gov ↗
PHASE1
Phase
RECRUITING
Status
60
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy
Idiopathic Inflammatory Myopathies
Systemic Sclerosis
Sjögren's Disease
Interventions
BIOLOGICAL:
XmAb657
Sponsor
Xencor, Inc.